Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Skin Beneath
Manchester, United Kingdomtheskinbeneath.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The Skin Beneath (TSB) is an innovative biotechnology and medical device company focused on advancing skin health through subdermal monitoring and targeted delivery systems. The company develops specialized technologies designed to monitor physiological changes beneath the skin's surface and provide precise therapeutic interventions for wound care and dermatological conditions. By integrating advanced sensors with biocompatible materials, TSB aims to improve clinical outcomes for patients with chronic wounds and complex skin disorders. Their approach combines medical-grade diagnostics with therapeutic applications to bridge the gap between topical treatments and systemic medicine.
- Therapeutic areas
- Dermatology
- Modalities
- DeviceSmall molecule
- Industry
- Biotech
Beyond the preview
Go deeper on The Skin Beneath.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on The Skin Beneath.